Serkan Yalin

Dr. Serkan Yalin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2021 in Blood Purification
Verified
Journal Article
Closed access
PDF file
SYSerkan Yalin
Serkan Yalin
MAMehmet Rıza Altıparmak
Mehmet Rıza Altıparmak
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
SYSerap Yadigar
Serap Yadigar
AMAhmet Murt
Ahmet Murt
CRClaudio Ronco
Claudio Ronco
Introduction: Severe acute respiratory syndrome coronavirus-2 may lead to high levels of expression of inflammatory cytokines. Medium cut-off (MCO) membranes may make greater clearances for large-middle molecules (including cytokines) than low-flux (LF) membranes. In this study, we aimed to evaluate the impact of MCO membranes on outcome of COVID-19 patients on hemodialysis (HD). Methods: Sixty COVID-19 HD patients were included in this study. The patients were categorized into 2 groups regarding type of HD membranes. Clinical data were taken from medical records. Results: Initial crp and ferritin levels, which are surragates of cytokine storm and severity of disease in COVID-19, were significantly higher in MCO membrane group compared to LF group (p = 0.037 and 0.000, respectively). Although there were more patients with severe disease in MCO group, there were no significant differences regarding need for intensive care unit and death. Conclusion: It may be an option to use MCO membranes in HD patients with COVID-19 in order to reduce cytokine levels and prevent cytokine storm.

9 June 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
SYSerkan Yalin
Serkan Yalin
ABAlev Bakir
Alev Bakir
STSinan Trabulus
Sinan Trabulus
NSNurhan Seyahi
Nurhan Seyahi
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak

19 February 2018 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
SYSerkan Yalin
Serkan Yalin
STSinan Trabulus
Sinan Trabulus
NSNurhan Seyahi
Nurhan Seyahi
MCMahir Cengiz
Mahir Cengiz
MCMustafa Erdogan Cicik
Mustafa Erdogan Cicik
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak

9 July 2024 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
ZDZeynep Toker Dincer
Zeynep Toker Dincer
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
SYSerkan Yalin
Serkan Yalin
STSinan Trabulus
Sinan Trabulus
NSNurhan Seyahi
Nurhan Seyahi
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak

12 April 2022 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
CScem sulu
cem sulu
SYSerkan Yalin
Serkan Yalin
TGTurgut Gürer
Turgut Gürer
MAMuhlis Cem Ar
Muhlis Cem Ar
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak

1 May 2012 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
CDC. Donadio
C. Donadio
AKA. Kanaki
A. Kanaki
AMAdoración Martín-Gómez
Adoración Martín-Gómez
SGSergio Garcia
Sergio Garcia
MPMeugenia Palacios-Gómez
Meugenia Palacios-Gómez
NANikolaos Afentakis
Nikolaos Afentakis
Introduction and Aims: There is no consensus on the best method to quantify hemodialysis and the optimal dosage of hemodialysis. Urea is the substance most often measured as a surrogate for the clearance of small molecules. In particular, Kt/V, that is the dialyzer clearance of urea, multiplied by the length of the dialysis session, divided by the volume of distribution of urea, is the most widely accepted indicator of adequacy of hemodialysis. Most commonly Kt/V is estimated, by means of Daugirdas formula, from the values of BUN (postdialysis/predialysis), ultrafiltration volume and postdialysis body weight.